RHEGMATOGENOUS RETINAL DETACHMENT: Progression and Characteristics of Postoperative Demarcation Lines

23.12.2024 | Brosh K, Semionov A, Hanhart J, Goldberg M, Potter MJ

Retina. 2025 Jan 1;45(1):30-34. doi: 10.1097/IAE.0000000000004280. PMID: 39378400

Between-eye correlation of ocular parameters

02.12.2024 | Hecht I, Shemer A, Vardi M, Braudo S, Dubinsky-Pertzov B, Or L, Pras E.

Can J Ophthalmol. 2024 Dec;59(6):e691-e698. doi: 10.1016/j.jcjo.2023.12.009. Epub 2024 Jan 11. PMID: 38219792.

Factors associated with keratoconus in Israel-A cross-sectional population-based study

02.12.2024 | Ben-Shaul O, Segal A, Schwartz S, Stein N, Hyams M, Saliba W, Mimouni M. Factors associated with keratoconus in Israel-A cross-sectional population-based study

Acta Ophthalmol. 2024 Nov;102(7):e1011-e1017. doi: 10.1111/aos.16706. Epub 2024 May 14. PMID: 38742987.

Higher risk and earlier onset glaucoma in Cushing's syndrome

02.12.2024 | Sharon Y, Shochat T, Rudman Y, Kushnir S, Zahavi A, Shimon I, Fleseriu M, Akirov A.

2024 Nov 5. doi: 10.1111/aos.16787. Epub ahead of print. PMID: 39498529.

Comparison of flanged polypropylene scleral intraocular lens fixation with scleral sutured fixation

02.12.2024 | Levy-Neuman S, Mendel L, Achiron A, Bukelman A, Weinberg T, Avizemer H, Schlesinger M, Marcovich AL, Kleinmann G.

Can J Ophthalmol. 2024 Dec;59(6):e653-e660. doi: 10.1016/j.jcjo.2024.03.014. Epub 2024 Apr 15. PMID: 38636552.

Branch retinal vein occlusion treated with anti-VEGF: to switch or not to switch?

02.12.2024 | Shor R, Segal O, Barequet D, Greenbaum E, Trivizki O, Loewenstein A, Rabina G.

 Can J Ophthalmol. 2024 Dec;59(6):e824-e829. doi: 10.1016/j.jcjo.2024.01.016. Epub 2024 Feb 22. PMID: 38395414

Colour vision deficiency is associated with increased prevalence of amblyopia, strabismus and ametropia: a large population study

02.12.2024 | Barayev E, Shapiro M, Greenbaum E, Ran Y, Gershoni A, Dotan G.

Br J Ophthalmol. 2024 Nov 12:bjo-2023-324564. doi: 10.1136/bjo-2023-324564. Epub ahead of print. PMID: 39532511

Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years

30.07.2023

מוגש בחסות באייר